High-dose, high-frequency infliximab: A novel treatment paradigm for hidradenitis suppurativa

Mondana H. Ghias, Andrew D. Johnston, Allison J. Kutner, Robert G. Micheletti, H. Dean Hosgood, Steven R. Cohen

Research output: Contribution to journalArticlepeer-review

14 Scopus citations

Fingerprint

Dive into the research topics of 'High-dose, high-frequency infliximab: A novel treatment paradigm for hidradenitis suppurativa'. Together they form a unique fingerprint.

Medicine & Life Sciences